PA-induced apoptosis in osteosarcoma cells. by Zeyu Zhan (22305085)

Subjects:

Tourism determinants’ marginal effects. by Sakar Hasan Hamza (20978818)

Subjects:

Descriptive statistics from 2005 to 2018. by Sakar Hasan Hamza (20978818)

Subjects:

Models 7 to 12: estimation results. by Sakar Hasan Hamza (20978818)

Subjects:

Scaling of overall health burden with yearly expenditure growth. by Margherita Molaro (17803989)

Subjects:

Models 1 to 6: estimation results. by Sakar Hasan Hamza (20978818)

Subjects:

Hausman test results. by Sakar Hasan Hamza (20978818)

Subjects:

Variable’s construction. by Sakar Hasan Hamza (20978818)

Subjects:

Moran’s I across countries. by Sakar Hasan Hamza (20978818)

Subjects:

Raw dataset. by Sakar Hasan Hamza (20978818)

Subjects:

Estimation of influenza transmission and death rates among individuals aged 0–17, 18–64, and 65+ in the United States using actual data. by Shuanglin Jing (11886368)

Subjects:

Estimation of transmission rates of influenza A and B in the United States using actual data. by Shuanglin Jing (11886368)

Subjects:

Effects of compound 4f on neuroinflammation in mice with KA-induced neurodegeneration. by Naoto Arimura (416442)

Subjects:

Top 20 IPA pathways of 2405 genes downregulated following KA treatment with a <i>P</i>-value of < 0.05. by Naoto Arimura (416442)

Subjects:

All data in the manuscript and supporting information. by Naoto Arimura (416442)

Subjects:

The effects of cannabinoid receptor antagonists against neuroprotective effects of compound 4f in KA-treated mice. by Naoto Arimura (416442)

Subjects:

Representative image data in Fig 5. by Naoto Arimura (416442)

Subjects:

Pharmacokinetics and pharmacodynamics of compound 4f in mice. by Naoto Arimura (416442)

Subjects:

The average transmission rates of different influenza strains. by Shuanglin Jing (11886368)

Subjects:

Effects of compound 4f on cognitive function in mice with KA-induced neurodegeneration. by Naoto Arimura (416442)

Subjects: